Skip to main navigation Skip to search Skip to main content

Treat-and-extend versus Pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study from routine clinical practice

Eloi Debourdeau*, Helene Beylerian, Vuong Nguyen, Daniel Barthelmes, Mark Gillies, Pierre Henry Gabrielle, Stela Vujosevic, Louise Otoole, Martin Puzo, Catherine Creuzot-Garcher, Benjamin Wolff, Vincent Daien, The Fight Retinal Blindness! Study Group

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

115 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Treat-and-extend versus Pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study from routine clinical practice'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science